Idera Pharmaceuticals Reports First Quarter 2021 Financial Results and Provides Corporate Update
EXTON, Pa., April 29, 2021 (GLOBE NEWSWIRE) — Idera Pharmaceuticals, Inc. (“Idera” or the “Company”)…
Month: April 2021
Pacific Biosciences of California, Inc. Announces First Quarter 2021 Financial Results
MENLO PARK, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Pacific Biosciences of California, Inc. (NASDAQ:…
Recro to Report Financial Results for First Quarter 2021 on May 6
Conference Call and Webcast Scheduled for Thursday, May 6 at 4:30 p.m. Eastern Time MALVERN,…
Nabriva Therapeutics to Report First Quarter 2021 Financial Results and Recent Corporate Highlights on May 6, 2021
DUBLIN, Ireland, April 29, 2021 (GLOBE NEWSWIRE) — Nabriva Therapeutics plc (NASDAQ: NBRV), a biopharmaceutical…
10x Genomics to Present at the BofA Securities 2021 Virtual Healthcare Conference
PLEASANTON, Calif., April 29, 2021 (GLOBE NEWSWIRE) — 10x Genomics, Inc. (Nasdaq: TXG), today announced…
Corvus Pharmaceuticals Provides Business Update and Reports First Quarter 2021 Financial Results
BURLINGAME, Calif., April 29, 2021 (GLOBE NEWSWIRE) — Corvus Pharmaceuticals, Inc. (Nasdaq: CRVS), a clinical-stage…
Spero Therapeutics to Provide Business Update and Report First Quarter 2021 Financial Results on Thursday, May 6, 2021
CAMBRIDGE, Mass., April 29, 2021 (GLOBE NEWSWIRE) — Spero Therapeutics, Inc. (Nasdaq: SPRO), a multi-asset clinical-stage…
Oncternal Therapeutics to Report First Quarter 2021 Financial Results and Provide Business Update
SAN DIEGO, April 29, 2021 (GLOBE NEWSWIRE) — Oncternal Therapeutics, Inc. (Nasdaq: ONCT), a clinical-stage…
MacroGenics Provides Update on Corporate Progress and First Quarter 2021 Financial Results
MARGENZA™ launched in mid-March Upcoming poster presentation of MGC018 initial Phase 1 clinical data at…
Motus GI to Release First Quarter Results and Provide a Business Update on May 13
FORT LAUDERDALE, Fla., April 29, 2021 (GLOBE NEWSWIRE) — Motus GI Holdings, Inc., (NASDAQ: MOTS)…
Y-mAbs to Announce First Quarter 2021 Financial and Operating Results on May 6, 2021
NEW YORK, April 29, 2021 (GLOBE NEWSWIRE) — Y-mAbs Therapeutics, Inc. (the “Company” or “Y-mAbs”)…
AmMax Bio to Present at the BofA Securities 2021 Virtual Healthcare Conference
REDWOOD CITY, Calif., April 29, 2021 (GLOBE NEWSWIRE) — AmMax Bio, Inc. (“AmMax”), a private…
Phathom Pharmaceuticals Announces Positive Topline Results from Pivotal Phase 3 Trial of Vonoprazan in Helicobacter pylori (H. pylori) Infection; Study Met All Primary and Secondary Endpoints
Both vonoprazan-based treatment regimens demonstrated superior eradication rates vs. a standard of care proton pump…
TELA Bio to Announce First Quarter 2021 Financial Results
MALVERN, Pa., April 29, 2021 (GLOBE NEWSWIRE) — TELA Bio, Inc. (“TELA”), a commercial-stage medical…
Infant Bacterial Therapeutics expands The Connection Study to include infants with a birth weight below 750 grams
After the Data Monitoring Committees’ review Infant Bacterial Therapeutics expands the enrollment criteria of The…
Zynerba Pharmaceuticals Presents Two Posters at the Society of Biological Psychiatry 2021 Virtual Meeting
DEVON, Pa., April 29, 2021 (GLOBE NEWSWIRE) — Zynerba Pharmaceuticals, Inc. (Nasdaq: ZYNE), the leader…
DEINOVE, ESPCI Paris and INRAE awarded grant following the call for proposals of the French “Antibiotic resistance” Priority Research Program
DEINOVE, ESPCI Paris and INRAE awarded grant following the call for proposals of the French“Antibiotic…
Saniona publishes its Annual Report for 2020
PRESS RELEASE April 29, 2021 Saniona (OMX: SANION), a clinical stage biopharmaceutical company focused on…
Eurobio Scientific: EXCEPTIONAL 2020 RESULTS
EXCEPTIONAL 2020 RESULTS EBITDA : € 88.2m (x12.6) Net income : € 73.5m (x23) Consolidation…